The restrained expression of NF-kB in renal tissue ameliorates folic acid induced acute kidney injury in mice

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Kumar, Dev ^a   Singla, Surinder K ^a   Puri, Veena ^a   Puri, Sanjeev ^a,b  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FOLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN P53; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTOR RELA; ANTIOXIDANT; PYRROLIDINE DERIVATIVE; PYRROLIDINE DITHIOCARBAMIC ACID; RELA PROTEIN, MOUSE; THIOCARBAMIC ACID DERIVATIVE;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAX GENE; BRUSH BORDER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG EFFECT; GENE EXPRESSION REGULATION; KIDNEY CORTEX NECROSIS; KIDNEY MEDULLA; KIDNEY TUBULE NECROSIS; MALE; MOUSE; NONHUMAN; NUCLEAR FACTOR KAPPA B GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RELA GENE; RENAL PROTECTION; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT DURATION; TUMOR SUPPRESSOR GENE; UPREGULATION; UREA NITROGEN BLOOD LEVEL; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY CORTEX; KIDNEY FUNCTION TEST; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRASTRUCTURE;

EUKARYOTA; MUS;

ACUTE KIDNEY INJURY; ANIMALS; ANTIOXIDANTS; FOLIC ACID; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY CORTEX; KIDNEY FUNCTION TESTS; MALE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; PYRROLIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIOCARBAMATES; TRANSCRIPTION FACTOR RELA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84920481360     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115947     Document Type: Article

References (83)

1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, et al. (2005) Beginning and ending supportive therapy for the kidney (BEST Kidney) investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294: 813-818.
2. Murugan R, Kellum JA (2011) Acute kidney injury: what's the prognosis? Nat Rev Nephrol 7: 209-217.
3. Coca SG, Singanamala S, Parikh CR (2012) Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81: 442-448.
4. Esson ML, Schrier RW (2002) Diagnosis and treatment of acute tubular necrosis. Ann Int Med 137: 744-752.
5. Liano F, Junco E, Pascual J, Madero R, Verde E (1998) The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kid Int Suppl 66: S16-S24
6. Liano F, Pascual J (9196) Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 50: 811-818.
7. Thadhani R, Pascual M, Bonventre JV (1996) Acute renal failure. N Engl J Med 334: 1448-1460.
8. Basile DP, Anderson MD, Sutton TA (2012) Pathophysiology of acute kidney injury. Compr Physiol 2: 1303-1353.
9. Edelstein CL (2008) Bio-markers of acute kidney injury. Adv Chronic Kid Dis 15: 222-234.
10. Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, et al. (2004) Plasma cytokine levels predict mortality in patients with acute renal failure. Kid Intl 65: 1357-1365.
11. Bonventre JV, Zuk A (2004) Ischemic acute renal failure: anti-inflammatory disease. Kid Intl 66: 480-485.
12. Friedewald JJ, Rabb H (2004) Inflammatory cells in ischemic acute renal failure. Kid Intl 66: 486-491.
13. Akcay A, Nguyen Q, Edelstein CL (2009) Mediators of inflammation in acute kidney injury. Mediators Inflamm 2009: 1-12. PMID 137072. doi.org/10.1155/2009/137072
14. Tadagavadi RK, Reeves WB (2010) Renal dendritic cells ameliorate nephrotoxic acute kidney injury. J Am Soc Nephrol 21: 53-63.
15. Linkermann A, De Zen F, Weinberg J, Kunzendorf U, Krautwald S (2012) Programmed necrosis in acute kidney injury. Nephrol Dial Transplant 27: 3412-3419.
16. Lopez-Franco O, Suzuki Y, Sanjuan G, Blanco J, Hernandez-Vargas P, et al. (2002) Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am J Pathol 161: 1497-1505.
17. Francescato HD, Costa RS, Scavone C, Coimbra TM (2007) Parthenolide reduces cisplatin-induced renal damage. Toxicology 230: 64-75.
18. Ramesh G, Reeves WB(2005) p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol 289: F166-F174.
19. Sanz AB, Sanchez-Niño MD, Ramos AM, Moreno JA, Santamaria B, et al. (2010) NF-KB in Renal Inflammation. J Am Soc Nephrol 21: 1254-1262.
20. Cao CC, Ding XQ, Ou ZL, Liu CF, Li P, et al. (2004) In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 65: 834-845.
21. Plümpe J, Malek NP, Bock CT, Rakemann T, Manns MP, et al. (2000) NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am J Physiol Gastrointest Liver Physiol 278: G173-83.
22. Sanz AB, Sanchez-Niño MD, Ramos AM, Moreno JA, Santamaria B, et al. (2010) NF-kappaB in renal inflammation. J Am Soc Nephrol 21: 1254-1262.
23. Guijarro C, Egido J (2001) Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int 59: 415-424.
24. Chen G, Shaw MH, Kim YG, Nunez G (2009) NOD like receptors: Role in innate immunity and inflammatory disease. Annu Rev Pathol 4: 365-398.
25. Lin B, Williams-Skipp C, Tao Y, Schleicher MS, Cano LL, et al. (1999) NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ 6: 570-582.
26. Jennewein C, Karl S, Baumann B, Micheau O, Debatin KM, et al. (2012) Identification of a novel proapoptotic role of NF-kB in the regulation of TRAIL- and CD95-mediated apoptosis of glioblastoma cells. Oncogene 31: 1468-1474
27. Wei Q, Dong G, Yang T, Megyesi J, Price PM, et al. (2007) Activation and involvement of p53 in cisplatin-induced nephrotoxicity. Am J Physiol (Renal Physiol) 293: F1282-F1291.
28. Zhou L, Fu P, Huang XR, Liu F, Lai KN, et al. (2010) Activation of p53 promotes renal injury in acute aristolochic acid nephropathy. J Am Soc Nephrol 21: 31-41.
29. Gudkov AV, Gurova KV, Komarova EA (2011) Inflammation and p53: A Tale of Two Stresses. Genes Cancer 2: 503-516.
30. Sutton TA, Hato T, Mai E, Yoshimoto M, Kuehl S, et al. (2013) p53 is renoprotective after ischemic kidney injury by reducing inflammation. J Am Soc Nephrol 24: 113-124.
31. Kim G, Ouzounova M, Quraishi AA, Davis A, Tawakkol N, et al. (2014) SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model. Oncogene PMID: 24531711. doi: 10.1038/onc.2014.4. [Epub ahead of print]
32. Wu H, Lozano G (1994) NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J Biol Chem 269: 20067-20074.
33. Jeong SJ, Radonovich M, Brady JN, Pise-Masison CA (2004) HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity. Blood 104: 1490-1497.
34. th edition.
35. rd edition.
36. th edition.
37. Goes N, Urmson J, Ramassar V, Halloran PF (1995) Ischemic acute tubular necrosis induces an extensive local cytokine response: evidence for induction of interferon-γ, transforming growth factor-β 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, andinterleukin-10. Transplantation 59: 565-572.
38. Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, et al. (2005) Maladaptive role of IL-6 in ischemic acute renal failure. Jl Am Soc Nephrol 16: 3315-3325.
39. Safirstein R, Megyesi J, Saggi SJ, Price PM, Poon M, et al. (1901) Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am Jl Physiol 261: F1095-F1101.
40. Thurman JM, Lenderink AM, Royer PA, Coleman KE, Zhou J, et al. (2007) C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion. Jl Immunol 178: 1819-1828.
41. Rice JC, Spence JS, Yetman DL, Safirstein RL (2002) Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney. Renal Failure 24: 703-723.
42. Matsushima H, Yonemura K, Ohishi K, Hishida A (1998) The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med 131: 518-526.
43. Baliga R, Ueda N, Walker PD, Shah SV (1999) Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 31: 971-997.
44. Gupta A, Puri V, Sharma R, Puri S (2012) Folic acid induces acute renal failure (ARF) by enhancing renal prooxidant state. Exp Toxicol Pathol 64: 225-232.
45. Kim HJ, Sato T, Rodríguez-Iturbe B, Vaziri ND (2011) Role of intrarenal angiotensin system activation, oxidative stress, inflammation, and impaired nuclear factor-erythroid-2-related factor 2 activity in the progression of focal glomerulosclerosis. J Pharmacol Exp Ther 337: 583-590
46. Ziyadeh FN, Wolf G (2008) Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 4: 39-45.
47. Jeong KH, Lee TW, Ihm CG, Lee SH, Moon JY, et al. (2009) Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats. Am J Nephrol 29: 274-282.
48. Sahu BD, Kuncha M, Sindhura GJ, Sistla R (2013) Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage. Phytomedicine 20: 453-460.
49. Lemay S, Rabb H, Postler G, Singh A (2000) Prominent and sustained up-regulation of GP130-signaling cytokines and of the chemokine MIP-2 in murine renal ischemia-reperfusion injury. Transplantation 69: 959-963.
50. Takase O, Marumo T, Hishikawa K, Fujita T, Quigg RJ, et al. (2008) NF-kappaB-dependent genes induced by proteinuria and identified using DNA microarrays. Clin Exp Nephrol 12: 181-188.
51. Egidoband J, Ruiz-Ortega M (2004) Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J Am Soc Nephrol 15: 1514-1529.
52. Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73: 994-1007.
53. Havasi A, Borkan SC (2011) Apoptosis and acute kidney injury. Kidney Int 80: 29-40.
54. Liang C, Zhang M, Sun SC (2006) beta-TrCP binding and processing of NF-kappaB2/p100 involve its phosphorylation at serines 866 and 870. Cell Signal 18: 1309-1317.
55. Senftleben U, Cao Y, Xiao G, Greten FR, Krähn G, et al. (2001) Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293: 1495-1499.
56. Xiao G, Harhaj EW, Sun SC (2001) NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 7: 401-409.
57. Collett GP, Campbell FC (2006) Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells. Carcinogenesis 27: 1285-1291.
58. Ryan KM, Ernst MK, Rice NR, Vousden KH (2000) Role of NF-kappaB in p53-mediated programmed cell death. Nature 404: 892-897.
59. Kaltschmidt JA, Davidson CM, Brown NH, Brand AH (2000) Rotation and asymmetry of the mitotic spindle direct asymmetric cell division in the developing central nervous system. Nat Cell Biol 2: 7-12.
60. Wang S, Kotamraju S, Konorev E, Kalivendi S, Joseph J, et al. (2002) Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide. Biochem J 367: 729-740.
61. Shimizu H, Yisireyili M, Higashiyama Y, Nishijima F, Niwa T (2013) Indoxyl sulfate up regulates renal expression of ICAM-1 via production of ROS and activation of NF-kB and p53 in proximal tubular cells. Life Sci 92: 143-148.
62. Campbell KJ, Rocha S, Perkins ND (2004) Active repression of antiapoptotic gene expression by ReIA(p65) NF-kB. Mol Cell 13: 853-865.
63. Gurova KV, Hill JE, Guo C, Prokvolit A, Burdelya LG, et al. (2005) Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors. Proc Natl Acad Sci 102: 17448-17453.
64. Shimizu H, Bolati D, Adijiang A, Enomoto A, Nishijima F, et al. (2010) Senescence and dysfunction of proximal tubular cells are associated with activated p53 expression by indoxyl sulfate. Am J Physiol Cell Physiol 299: C1110-C1117.
65. Shimizu H, Bolati D, Adijiang A, Muteliefu G, Enomoto A, et al. (2011) NF-kB plays an important role in indoxyl sulfate-induced cellular senescence, fibrotic gene expression, and inhibition of proliferation in proximal tubular cells. Am J Physiol Cell Physiol 301: C1201-C1212.
66. Shimizu H, Yisireyili M, Nishijima F, Niwa T (2012) Indoxyl sulfate enhances p53-TGF-β1-Smad3 pathway in proximal tubular cells. Am J Nephrol 37: 97-103.
67. Basile DP (2007) The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function.Kidney Int 72: 151-156.
68. Massy ZA, Guijarro C, O'Donnell MP, Kim Y, Kashtan CE, et al. (1997) The central role of nuclear factor-kappaB in mesangial cell activation. Kidney Int 71: S76-S79.
69. Blagosklonny MV (2002) P53: An ubiquitous target of anticancer drugs. International Journal of Cancer 98: 161-166.
70. Powell DJ, Hrstka R, Candeias M, Bourougaa K, Vojtesek B, et al. (2008) Stress-dependent changes in the properties of p53 complexes by the alternative translation product p53/47. Cell Cycle 7: 950-959
71. Gudkov AV, Komarova EA (2010) Pathologies Associated with the p53 Response. Cold Spring Harb Perspect Biol 2: a001180 doi: 10.1101/cshperspect.a001180
72. Chow BM, Li YQ, Wong CS (2000) Radiation-induced apoptosis in the adult central nervous system is p53-dependent. Cell Death Differ 7: 712-720.
73. Jiang M, Wei Q, Wang J, Du Q, Yu J, et al. (2006) Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis. Oncogene 25: 4056-4066.
74. Hur E, Garip A, Camyar A, Ilgun S, Ozisik M, et al. (2013) The effects of vitamin D on gentamicin-induced acute kidney injury in experimental rat model. Int J Endocrinol 2013: ID 313528, 7 pages. doi: 10.1155/2013/313528.
75. Olsen TS, Hansen HE (1990) Ultrastructure of medullary tubules in ischemic acute tubular necrosis and acute interstitial nephritis in man. APMIS 98: 1139-1148.
76. Pease DC (1955) Fine structures of the kidney seen by electron microscopy. J Histochem Cytochem 3: 295-308.
77. Bengatta S, Arnould C, Letavernier E, Monge M, de Préneuf HM, et al. (2009) MMP9 and SCF protect from apoptosis in acute kidney injury. J Am Soc Nephrol 20: 787-797.
78. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, et al. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805.
79. Aebi H (1984) Catalase in vitro. Methods Enzymol 105: 121-126.
80. Kono Y (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186: 189-195.
81. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358.
82. Degli EM (2002) Measuring mitochondrial reactive oxygen species. Methods 26: 335-340.
83. Hissin PJ, Hilf R (1976) A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 74: 214-226.